Financial Toxicity in Women with Endometriosis: Psychometric Validation of the Polish COST-FACIT with Analysis of Demographic and Clinical Factors
article
OA: gold
CC0
AI-generated summary
The Polish COST-FACIT scale was validated for women with endometriosis, revealing that longer symptom duration, distance to care, and healthcare costs correlated with financial toxicity, while education, employment, and income were associated with better financial well-being.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: Endometriosis is a chronic condition associated with substantial healthcare costs, diagnostic delays and long-term impairment in quality of life. Despite the recognized economic burden, patient-reported financial distress remains insufficiently studied. The aim of this study was to adapt and validate the Polish version of the Comprehensive Score for Financial Toxicity (COST-FACIT) for use in women with endometriosis, as well as to examine demographic and clinical factors associated with financial toxicity. Methods: A cross-sectional study was conducted among Polish women with endometriosis using an online survey. The COST-FACIT was adapted following standard forward–backward translation procedures, with FACIT approval. Psychometric evaluation included internal consistency, construct validity, convergent validity with the Financial Well-Being Scale, and test–retest reliability. Exploratory and confirmatory factor analyses were performed, and multivariable models were used to identify factors associated with financial toxicity. Results: The adapted scale demonstrated good psychometric properties, with excellent internal consistency (Cronbach’s α = 0.92; McDonald’s ω = 0.92) and strong test–retest reliability (r = 0.87). Exploratory factor analysis supported a two-factor structure of the instrument. COST-FACIT scores were strongly correlated with financial well-being (r = 0.78). Higher education, stable employment and higher income were associated with better financial well-being, whereas longer symptom duration, greater distance to care and higher healthcare expenditures were associated with worse scores. Conclusions: The Polish COST-FACIT demonstrated good psychometric properties and may serve as a useful instrument for assessing financial toxicity in women with endometriosis. The results highlight the financial burden of the disease and support the use of patient-reported measures to identify individuals at risk of financial distress and reduced quality of life. This tool may facilitate clinical research and improve patient-centered care.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- The direct and indirect costs associated with endometriosis: a systematic literature review 2016
- Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States 2018
- Understanding diagnostic delay for endometriosis: A scoping review using the social-ecological framework 2024
- Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study 2025
References (23)
- Global, regional, and national burden of endometriosis among women of childbearing age from 1990 to 2021: a cross-sectional analysis from the 2021 global burden of disease study via openalex
- Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United States via openalex
- The direct and indirect costs associated with endometriosis: a systematic literature review via openalex
- Understanding diagnostic delay for endometriosis: A scoping review using the social-ecological framework via openalex
- W3006973895 via openalex
- W3120821654 via openalex
- W3153317972 via openalex
- W3199030893 via openalex
- W4211222507 via openalex
- W2091996489 via openalex
- W4214875810 via openalex
- W4294044501 via openalex
- W4390296018 via openalex
- W4400113835 via openalex
- W4403193537 via openalex
- W4403559395 via openalex
- W4408808993 via openalex
- W4409042622 via openalex
- W4411352872 via openalex
- W4214754424 via openalex
- W2115988342 via openalex
- W2529430742 via openalex
- W2779791612 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK